Skip to main content

Rheumatic Heart Disease Australia

RHD Resouces

Latest ATAGI mRNA vaccine advice: guidance for people with RHD Fact Checked

Written by 

Anna Ralph

The Australian Technical Advisory Group on Immunization (ATAGI) statement released on 30th July 2021 describes the very low risk of myopericarditis (that is, myocarditis, pericarditis or both) following mRNA COVID-19 vaccines. These vaccines are still recommended and considered safe for people with rheumatic heart disease. ATAGI does recommend that people should seek advice about the timing of vaccination and if any additional precautions are recommended. RHDAustralia has prepared specific guidance for those with a history of ARF and RHD. Enquiries can be directed to

COVID-19 vaccination – ATAGI clinical guidance on COVID-19 vaccine in Australia in 2021 (

COVID-19 vaccination – Guidance on Myocarditis and Pericarditis after mRNA COVID-19 vaccines (